$MLRT
Metalert, Inc. Stock $mlrt

$mlrt Overview Financials Valuation SEC Filings Company Website

2022 Q1 Form 10-Q Financial Statement

#000149315222013691 Filed on May 16, 2022

Income Statement

Concept	2022 Q1	2021 Q1
Revenue	$168.5K	$230.5K
YoY Change	-26.9%	138.35%
Cost Of Revenue	$94.86K	$147.2K
YoY Change	-35.54%	324.86%
Gross Profit	$73.65K	$83.36K
YoY Change	-11.64%	34.28%
Gross Profit Margin	43.71%	36.16%
Selling, General & Admin	$71.65K	$57.99K
YoY Change	23.56%	-23.14%
% of Gross Profit	97.28%	69.56%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$8.335K	$1.188K
YoY Change	601.6%	-70.85%
% of Gross Profit	11.32%	1.43%
Operating Expenses	$293.6K	$285.0K
YoY Change	3.02%	0.95%
Operating Profit	-$219.9K	-$201.6K
YoY Change	9.09%	-8.45%
Interest Expense	-$36.09K	-$22.79K
YoY Change	58.36%	-112.02%
% of Operating Profit
Other Income/Expense, Net	$25.54K	-$88.83K
YoY Change	-128.75%	-139.11%
Pretax Income	-$194.4K	-$290.4K
YoY Change	-33.07%	-4303.04%
Income Tax
% Of Pretax Income
Net Earnings	-$194.4K	-$290.4K
YoY Change	-33.07%	-4304.21%
Net Earnings / Revenue	-115.35%	-125.99%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	-$825.40	-$1.772K
COMMON SHARES
Basic Shares Outstanding	235.5M shares	163.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q1	2021 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$46.26K	$412.7K
YoY Change	-88.79%	303.4%
Cash & Equivalents	$44.89K	$408.0K
Short-Term Investments	$1.370K	$4.676K
Other Short-Term Assets	$15.66K	$70.13K
YoY Change	-77.67%	408.96%
Inventory	$84.36K	$53.72K
Prepaid Expenses
Receivables	$31.67K	$50.23K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$178.0K	$586.8K
YoY Change	-69.67%	238.53%
LONG-TERM ASSETS
Property, Plant & Equipment	$84.13K	$13.17K
YoY Change	538.77%	-8.08%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$84.13K	$13.17K
YoY Change	538.77%	-55.09%
TOTAL ASSETS
Total Short-Term Assets	$178.0K	$586.8K
Total Long-Term Assets	$84.13K	$13.17K
Total Assets	$262.1K	$599.9K
YoY Change	-56.31%	196.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$134.1K	$157.6K
YoY Change	-14.89%	-15.87%
Accrued Expenses	$310.4K	$291.9K
YoY Change	6.32%	-30.66%
Deferred Revenue	$29.50K	$31.28K
YoY Change	-5.69%	-44.99%
Short-Term Debt	$1.805M
YoY Change
Long-Term Debt Due	$16.15K	$11.72K
YoY Change	37.8%
Total Short-Term Liabilities	$3.131M	$2.981M
YoY Change	5.03%	-19.21%
LONG-TERM LIABILITIES
Long-Term Debt	$140.9K	$217.9K
YoY Change	-35.35%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$140.9K	$217.9K
YoY Change	-35.35%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.131M	$2.981M
Total Long-Term Liabilities	$140.9K	$217.9K
Total Liabilities	$3.271M	$3.198M
YoY Change	2.28%	-13.31%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.25M	-$24.89M
YoY Change	5.44%	5.47%
Common Stock	$23.85K	$18.60K
YoY Change	28.26%	132.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.009M	-$2.599M
YoY Change
Total Liabilities & Shareholders Equity	$262.1K	$599.9K
YoY Change	-56.31%	196.04%

Cashflow Statement

Concept	2022 Q1	2021 Q1
OPERATING ACTIVITIES
Net Income	-$194.4K	-$290.4K
YoY Change	-33.07%	-4304.21%
Depreciation, Depletion And Amortization	$8.335K	$1.188K
YoY Change	601.6%	-70.85%
Cash From Operating Activities	-$141.7K	-$76.73K
YoY Change	84.67%	-53.69%
INVESTING ACTIVITIES
Capital Expenditures		$6.480K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.260K
YoY Change	-100.0%	-99.14%
Cash From Investing Activities		-$5.222K
YoY Change		-103.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$48.25K	$413.0K
YoY Change	-88.32%	-5061.48%
NET CHANGE
Cash From Operating Activities	-$141.7K	-$76.73K
Cash From Investing Activities		-$5.222K
Cash From Financing Activities	$48.25K	$413.0K
Net Change In Cash	-$93.45K	$331.1K
YoY Change	-128.22%	-1291.23%
FREE CASH FLOW
Cash From Operating Activities	-$141.7K	-$76.73K
Capital Expenditures		$6.480K
Free Cash Flow	-$141.7K	-$83.21K
YoY Change	70.29%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001375793
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021Q1	GTXO	Grant From Care Loans GrantFromCareLoans		usd
CY2022Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2021Q1	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2022Q1	GTXO	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne		usd
CY2021Q1	GTXO	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants		usd
CY2021Q1	GTXO	Issuance Of Common Stock For Conversion Of Warrants One IssuanceOfCommonStockForConversionOfWarrantsOne		usd
CY2021Q1	GTXO	Adjustments To Additional Paid In Capital Deemed Dividend On Fair Value Of Warrants And Conversion Feature Associated With Preferred Stock AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnFairValueOfWarrantsAndConversionFeatureAssociatedWithPreferredStock		usd
CY2021Q1	GTXO	Grant From Care Loans GrantFromCareLoans		usd
CY2021Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts		usd
CY2022Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q1	GTXO	Bonus Shares Issued BonusSharesIssued		usd
CY2022Q1	GTXO	Payments For Proceeds On Loan PaymentsForProceedsOnLoan		usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2022Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2021Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
CY2021Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2021Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2022Q1	GTXO	Deemed Dividend DeemedDividend		usd
CY2022Q1	GTXO	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock		usd
CY2022Q1	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2022Q1	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount		usd
CY2022Q1	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022Q1	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations		shares
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-53046
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	GTX Corp
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0493446
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	117 W. 9th Street
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1214
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90015
CY2022Q1	dei	City Area Code CityAreaCode	213
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	489-3019
CY2022Q1	dei	Security12b Title Security12bTitle	None
CY2022Q1	dei	Trading Symbol TradingSymbol	GTXO
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	239702479	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44892	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138342	usd
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	31672	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13735	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	84361	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1370	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	15662	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	55016	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	177957	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	307816	usd
CY2022Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	84126	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	92461	usd
CY2022Q1	us-gaap	Assets Assets	262083	usd
CY2021Q4	us-gaap	Assets Assets	400277	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	134144	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	182610	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	310363	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327293	usd
CY2022Q1	GTXO	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	835810	usd
CY2021Q4	GTXO	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	839810	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29496	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37350	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	21715	usd
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	9153	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2022Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2022Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	982792	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	976545	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	63885	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3130642	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3136981	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	140847	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142917	usd
CY2022Q1	us-gaap	Liabilities Liabilities	3271489	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3279898	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	238502483	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	238502483	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	224502479	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	224502479	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	23850	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	22450	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23214412	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23151212	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26247769	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26053384	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	262083	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400277	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168516	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230521	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	94863	usd
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	147162	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	73653	usd
CY2021Q1	us-gaap	Gross Profit GrossProfit	83359	usd
CY2022Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	123765	usd
CY2021Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	126802	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	98162	usd
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	100170	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10541	usd
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9936	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61107	usd
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48051	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	293576	usd
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	284959	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-219922	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-201600	usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66036	usd
CY2022Q1	GTXO	Gain Loss On Marketable Securities GainLossOnMarketableSecurities	-1095	usd
CY2021Q1	GTXO	Gain Loss On Marketable Securities GainLossOnMarketableSecurities	1768	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6247	usd
CY2022Q1	GTXO	Grant From Care Loans GrantFromCareLoans	67870	usd
CY2022Q1	GTXO	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-34990	usd
CY2021Q1	GTXO	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-24559	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25538	usd
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-88827	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-194385	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290427	usd
CY2021Q1	GTXO	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne	425000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-194385	usd
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-715427	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235502478	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163886808	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39600	usd
CY2022Q1	GTXO	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants	25000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-194385	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3104097	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61750	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	171873	usd
CY2021Q1	GTXO	Issuance Of Preferred Stock For Financing IssuanceOfPreferredStockForFinancing	425000	usd
CY2021Q1	GTXO	Stock Issuance Of Common Stock For Financings StockIssuanceOfCommonStockForFinancings	3275	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	131736	usd
CY2021Q1	GTXO	Inpixon Loan Reduction Correction InpixonLoanReductionCorrection	2340	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290427	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-2598550	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-194385	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290427	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8335	usd
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1188	usd
CY2022Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1095	usd
CY2021Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1768	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39600	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	61750	usd
CY2022Q1	GTXO	Grant From Care Loans GrantFromCareLoans	67870	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6246	usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66036	usd
CY2022Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	35332	usd
CY2021Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	24559	usd
CY2021Q1	GTXO	Bonus Shares Issued BonusSharesIssued	3275	usd
CY2021Q1	GTXO	Payments For Proceeds On Loan PaymentsForProceedsOnLoan	-2340	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17938	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9746	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13897	usd
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-60418	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-39354	usd
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15536	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-21357	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7318	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	23750	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	34574	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7754	usd
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6075	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-141695	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76730	usd
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6480	usd
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1258	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5222	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9180	usd
CY2021Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	425000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	25000	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	25000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1755	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	9180	usd
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	11957	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48245	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	413043	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-93450	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	331091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76912	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44892	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230521	usd
CY2022Q1	GTXO	Short Term Borrowings One ShortTermBorrowingsOne	63885	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	408003	usd
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	298	usd
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	171873	usd
CY2021Q1	GTXO	Deemed Dividend DeemedDividend	425000	usd
CY2021Q1	GTXO	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	1000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2022Q1	GTXO	Working Capital WorkingCapital	2952685	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168516	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230521	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168516	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
CY2022Q1	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zKb1RtSnOby5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_zF6ppTX2tnP1">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zJDePi0vIZ43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zg8wKjbgUbR5">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of March 31, 2022, the Company had three customers representing approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfkAjJ6CTV1" title="Concentration risk, percentage">40</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zthBqsiSRWr1" title="Concentration risk, percentage">26</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zyXZzOFMuA7b" title="Concentration risk, percentage">13</span>% of sales, respectively, and four customers representing approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAYgIxb5F5Wl" title="Concentration risk, percentage">15</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zGYQwhX1gec1" title="Concentration risk, percentage">14</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z2APzKmxO0p3" title="Concentration risk, percentage">12</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zqfkOSpDFNj7" title="Concentration risk, percentage">10</span>% of total accounts receivable, respectively (the <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_z4QHXKfCSJx8" title="Concentration risk, percentage">26</span>% in sales and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zQ0nC8Cqrvz3" title="Concentration risk, percentage">14</span>% in receivables represents all sales made through our online store and consists of approximately 2,000 different customers). As of March 31, 2021, the Company had three customers representing approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zL790Yha8Mel" title="Concentration risk, percentage">22</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zvn4RAsu73Pc" title="Concentration risk, percentage">13</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zKDVxR2IoeNi" title="Concentration risk, percentage">12</span>% of sales, respectively, and two customers representing approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zb9wVBLYutD8" title="Concentration risk, percentage">75</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCwmhsHRaQ18" title="Concentration risk, percentage">8</span>% of total accounts receivable, respectively (of the <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zZEyeKCkW4d9" title="Concentration risk, percentage">75</span>% this represents all sales made through our online store and consists of approximately 2,000 different customers).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	GTXO	Investment Owned Description InvestmentOwnedDescription	The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations
CY2019	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10889	shares
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8500	shares
CY2021Q4	GTXO	Short Term Borrowings One ShortTermBorrowingsOne	40640	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1370	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2020Q4	GTXO	Convertible Debt Liability ConvertibleDebtLiability	0	usd
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	169241667	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	187159131	shares
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	58511	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	71936	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25850	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25322	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	84361	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	429908	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	421573	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84126	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2022Q1	us-gaap	Depreciation Depreciation	8335	usd
CY2021Q1	us-gaap	Depreciation Depreciation	1188	usd
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	9153	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2022Q1	us-gaap	Notes Payable NotesPayable	80038	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	122593	usd
CY2021Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2022Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	9153	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7083	usd
CY2022Q1	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	140847	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142917	usd
CY2022Q1	GTXO	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	150000	usd
CY2021Q4	GTXO	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	217870	usd
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	982792	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	4000000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39600	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	49250000	shares
CY2022Q1	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.0025
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	10000000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	39250000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	GTXO	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2021Q1	GTXO	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1200000	shares
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	11400	usd
CY2022Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001375793
CY2022Q1	dei	Amendment Flag AmendmentFlag	false
CY2022Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q1	dei	Document Type DocumentType	10-Q
CY2022Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q1	dei	Document Period End Date DocumentPeriodEndDate	2022-03-31
CY2022Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q1	dei	Entity File Number EntityFileNumber	000-53046
CY2022Q1	dei	Entity Registrant Name EntityRegistrantName	GTX Corp
CY2022Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0493446
CY2022Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	117 W. 9th Street
CY2022Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1214
CY2022Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2022Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90015
CY2022Q1	dei	City Area Code CityAreaCode	213
CY2022Q1	dei	Local Phone Number LocalPhoneNumber	489-3019
CY2022Q1	dei	Security12b Title Security12bTitle	None
CY2022Q1	dei	Trading Symbol TradingSymbol	GTXO
CY2022Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q1	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	239702479	shares
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	44892	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138342	usd
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	31672	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13735	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	84361	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1370	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	15662	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	55016	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	177957	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	307816	usd
CY2022Q1	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	84126	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	92461	usd
CY2022Q1	us-gaap	Assets Assets	262083	usd
CY2021Q4	us-gaap	Assets Assets	400277	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	134144	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	182610	usd
CY2022Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	310363	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327293	usd
CY2022Q1	GTXO	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	835810	usd
CY2021Q4	GTXO	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	839810	usd
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	29496	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37350	usd
CY2022Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	21715	usd
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	9153	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2022Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2022Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	982792	usd
CY2021Q1	us-gaap	Professional Fees ProfessionalFees	100170	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	10541	usd
CY2021Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	9936	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	976545	usd
CY2022Q1	us-gaap	Notes Payable Current NotesPayableCurrent	63885	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	3130642	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3136981	usd
CY2022Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	140847	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142917	usd
CY2022Q1	us-gaap	Liabilities Liabilities	3271489	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3279898	usd
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	238502483	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	238502483	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	224502479	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	224502479	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	23850	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	22450	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23214412	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23151212	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26247769	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26053384	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	262083	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400277	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168516	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230521	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	94863	usd
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	147162	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	73653	usd
CY2021Q1	us-gaap	Gross Profit GrossProfit	83359	usd
CY2022Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	123765	usd
CY2021Q1	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	126802	usd
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	98162	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	61107	usd
CY2021Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	48051	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	293576	usd
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	284959	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-219922	usd
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-201600	usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66036	usd
CY2022Q1	GTXO	Gain Loss On Marketable Securities GainLossOnMarketableSecurities	-1095	usd
CY2021Q1	GTXO	Gain Loss On Marketable Securities GainLossOnMarketableSecurities	1768	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6247	usd
CY2022Q1	GTXO	Grant From Care Loans GrantFromCareLoans	67870	usd
CY2022Q1	GTXO	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-34990	usd
CY2021Q1	GTXO	Interest Expense Income And Financing Costs InterestExpenseIncomeAndFinancingCosts	-24559	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25538	usd
CY2021Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-88827	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-194385	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290427	usd
CY2021Q1	GTXO	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne	425000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-194385	usd
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-715427	usd
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	235502478	shares
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	163886808	shares
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39600	usd
CY2022Q1	GTXO	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants	25000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-194385	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3104097	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	61750	usd
CY2021Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	171873	usd
CY2021Q1	GTXO	Issuance Of Preferred Stock For Financing IssuanceOfPreferredStockForFinancing	425000	usd
CY2021Q1	GTXO	Stock Issuance Of Common Stock For Financings StockIssuanceOfCommonStockForFinancings	3275	usd
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	131736	usd
CY2021Q1	GTXO	Inpixon Loan Reduction Correction InpixonLoanReductionCorrection	2340	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290427	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-2598550	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-194385	usd
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-290427	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	8335	usd
CY2021Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1188	usd
CY2022Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-1095	usd
CY2021Q1	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	1768	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	39600	usd
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	61750	usd
CY2022Q1	GTXO	Grant From Care Loans GrantFromCareLoans	67870	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	6246	usd
CY2021Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-66036	usd
CY2022Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	35332	usd
CY2021Q1	us-gaap	Financing Interest Expense FinancingInterestExpense	24559	usd
CY2021Q1	GTXO	Bonus Shares Issued BonusSharesIssued	3275	usd
CY2021Q1	GTXO	Payments For Proceeds On Loan PaymentsForProceedsOnLoan	-2340	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17938	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9746	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-13897	usd
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-60418	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-39354	usd
CY2021Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	15536	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-21357	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7318	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	23750	usd
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	34574	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-7754	usd
CY2021Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-6075	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-141695	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-76730	usd
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6480	usd
CY2021Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1258	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5222	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	9180	usd
CY2021Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	425000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	25000	usd
CY2022Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	25000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1755	usd
CY2022Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	9180	usd
CY2021Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	11957	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	48245	usd
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	413043	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-93450	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	331091	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76912	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	44892	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	408003	usd
CY2021Q1	us-gaap	Interest Paid Net InterestPaidNet	298	usd
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	171873	usd
CY2021Q1	GTXO	Deemed Dividend DeemedDividend	425000	usd
CY2021Q1	GTXO	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	1000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-3009406	usd
CY2022Q1	GTXO	Working Capital WorkingCapital	2952685	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168516	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230521	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	168516	usd
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	230521	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
CY2022Q1	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase
CY2022Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_zKb1RtSnOby5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_863_zF6ppTX2tnP1">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84E_eus-gaap--ConcentrationRiskCreditRisk_zJDePi0vIZ43" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_869_zg8wKjbgUbR5">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">As of March 31, 2022, the Company had three customers representing approximately <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220331__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zfkAjJ6CTV1" title="Concentration risk, percentage">40</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zthBqsiSRWr1" title="Concentration risk, percentage">26</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zyXZzOFMuA7b" title="Concentration risk, percentage">13</span>% of sales, respectively, and four customers representing approximately <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zAYgIxb5F5Wl" title="Concentration risk, percentage">15</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zGYQwhX1gec1" title="Concentration risk, percentage">14</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z2APzKmxO0p3" title="Concentration risk, percentage">12</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zqfkOSpDFNj7" title="Concentration risk, percentage">10</span>% of total accounts receivable, respectively (the <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_z4QHXKfCSJx8" title="Concentration risk, percentage">26</span>% in sales and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20220101__20220331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zQ0nC8Cqrvz3" title="Concentration risk, percentage">14</span>% in receivables represents all sales made through our online store and consists of approximately 2,000 different customers). As of March 31, 2021, the Company had three customers representing approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zL790Yha8Mel" title="Concentration risk, percentage">22</span>%, <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zvn4RAsu73Pc" title="Concentration risk, percentage">13</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zKDVxR2IoeNi" title="Concentration risk, percentage">12</span>% of sales, respectively, and two customers representing approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zb9wVBLYutD8" title="Concentration risk, percentage">75</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zCwmhsHRaQ18" title="Concentration risk, percentage">8</span>% of total accounts receivable, respectively (of the <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210331__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerMember_zZEyeKCkW4d9" title="Concentration risk, percentage">75</span>% this represents all sales made through our online store and consists of approximately 2,000 different customers).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1370	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2020Q4	GTXO	Convertible Debt Liability ConvertibleDebtLiability	0	usd
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	169241667	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	187159131	shares
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2022Q1	GTXO	Investment Owned Description InvestmentOwnedDescription	The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations
CY2019	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10889	shares
CY2020Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8500	shares
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	58511	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	71936	usd
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25850	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25322	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	84361	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	429908	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	421573	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84126	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2022Q1	us-gaap	Depreciation Depreciation	8335	usd
CY2021Q1	us-gaap	Depreciation Depreciation	1188	usd
CY2022Q1	GTXO	Short Term Borrowings One ShortTermBorrowingsOne	63885	usd
CY2021Q4	GTXO	Short Term Borrowings One ShortTermBorrowingsOne	40640	usd
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	9153	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	39600	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	49250000	shares
CY2022Q1	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.0025
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	10000000	shares
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2022Q1	us-gaap	Notes Payable NotesPayable	80038	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	122593	usd
CY2021Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2021Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2022Q1	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	9153	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7083	usd
CY2022Q1	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	140847	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142917	usd
CY2022Q1	GTXO	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	150000	usd
CY2021Q4	GTXO	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	217870	usd
CY2022Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	982792	usd
CY2022Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q1	us-gaap	Stock Issued During Period Shares Issued For Services StockIssuedDuringPeriodSharesIssuedForServices	4000000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	39250000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q1	GTXO	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2021Q1	GTXO	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	1200000	shares
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	11400	usd

Files In Submission

Name	View Source	Status
0001493152-22-013691-index-headers.html	Edgar Link	pending
0001493152-22-013691-index.html	Edgar Link	pending
0001493152-22-013691.txt	Edgar Link	pending
0001493152-22-013691-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
gtxo-20220331.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
gtxo-20220331_cal.xml	Edgar Link	unprocessable
gtxo-20220331_def.xml	Edgar Link	unprocessable
gtxo-20220331_pre.xml	Edgar Link	unprocessable
gtxo-20220331_lab.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLRT
Metalert, Inc. Stock $mlrt

2022 Q1 Form 10-Q Financial Statement

#000149315222013691 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT Metalert, Inc. Stock $mlrt

2022 Q1 Form 10-Q Financial Statement

#000149315222013691 Filed on May 16, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT
Metalert, Inc. Stock $mlrt